A novel bispecific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells to target blood vessels and vasculogenic mimicry of malignant gliomas.
about
Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.Stem cell-based therapies for tumors in the brain: are we there yet?UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice.An Efficient Bivalent Cyclic RGD-PIK3CB siRNA Conjugate for Specific Targeted Therapy against Glioblastoma In Vitro and In VivoOverview of advances in vasculogenic mimicry - a potential target for tumor therapy
P2860
A novel bispecific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells to target blood vessels and vasculogenic mimicry of malignant gliomas.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A novel bispecific immunotoxin ...... mimicry of malignant gliomas.
@ast
A novel bispecific immunotoxin ...... mimicry of malignant gliomas.
@en
type
label
A novel bispecific immunotoxin ...... mimicry of malignant gliomas.
@ast
A novel bispecific immunotoxin ...... mimicry of malignant gliomas.
@en
prefLabel
A novel bispecific immunotoxin ...... mimicry of malignant gliomas.
@ast
A novel bispecific immunotoxin ...... mimicry of malignant gliomas.
@en
P2093
P2860
P356
P1476
A novel bispecific immunotoxin ...... mimicry of malignant gliomas.
@en
P2093
Jihui Wang
Xinlin Sun
Yonghong Zhang
P2860
P304
P356
10.2147/DDDT.S79475
P407
P577
2015-06-11T00:00:00Z